Masitinib is safe and effective for the treatment of canine mast cell tumors.
Authors
Hahn KA, Ogilvie G, Oglivie G, Rusk T, Devauchelle P, Legendre A, Powers B, Leventhal PS, Kinet JP, Palmerini F, Dubreuil P, Moussy A, Hermine O
Summary
Activation of the KIT receptor tyrosine kinase is associated with the development of canine mast cell tumors (MCT).
Read the article